+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

The chlordiazepoxide pentylenetetrazole discrimination characterization of drug interactions and homeostatic responses to drug challenges

The chlordiazepoxide pentylenetetrazole discrimination characterization of drug interactions and homeostatic responses to drug challenges

Psychopharmacology 96(1): 15-20

Rats were trained to discriminate chlordiazepoxide (CDP) from pentylenetetrazol (PTZ) in a two-lever food motivated discrimination task. Training drug doses were adjusted until subjects emitted approximately 50% of their responses on each of the two drug-appropriate levers during saline injection tests. Tests that followed injection of CDP/PTZ combinations illustrated a reciprocal antagonism between the two drugs. Saline-injection tests that followed large dose injections of CDP revealed a period of predominantly PTZ-appropriate responding that persisted after the initial period of predominantly CDP-appropriate responding. These data are interpreted to suggest that, unlike some other drugs that have been shown to antagonize the behavioral and CNS effects of benzodiazepines, the interoceptive stimulus generated the PTZ occupies a position opposite to that of CDP along some single affective continuum. In addition, these data suggest that drug/drug (DD) discriminations are capable of characterizing the interactions between training drugs. Finally, the data suggest that the CDP/PTZ discrimination is a sensitive detector of bidirectional shifts in interoceptive stimulus state along the CDP/PTZ continuum.

(PDF 0-2 workdays service: $29.90)

Accession: 006614327

Download citation: RISBibTeXText

PMID: 3147473

Related references

Comparison of drug vs drug discrimination paradigms using chlordiazepoxide vs caffeine and chlordiazepoxide vs pentylenetetrazole. 1985

Three-choice chlordiazepoxide, saline, and pentylenetetrazole discrimination in rats: Cross-generalization between drug and (olfactory) alarm substance stimuli. Experimental and Clinical Psychopharmacology 4(4): 373-378, 1996

Assessment of interactions of CCK and CCK antagonists with chlordiazepoxide in drug discrimination learning. Drug & Alcohol Dependence 60(Suppl 1): S126, 1 December, 2000

Differential interactions between chlordiazepoxide, pentobarbital and benzodiazepine antagonists Ro 15-1788 and CGS 8216 in a drug discrimination procedure. Pharmacology, Biochemistry, and Behavior 24(4): 999-1005, 1986

Predicting drug-drug interactions from in vitro drug metabolism data: challenges and recent advances. Current Opinion in Drug Discovery & Development 12(1): 81-89, 2009

Scientific and regulatory perspectives on metabolizing enzyme-transporter interplay and its role in drug interactions: challenges in predicting drug interactions. Molecular Pharmaceutics 6(6): 1766-1774, 2010

Chlordiazepoxide vs caffeine drug discrimination in the rat. 1985

Cue dimensionality in the three-choice pentylenetetrazole-saline-chlordiazepoxide discrimination task. Behavioural Pharmacology 2(4 and 5): 417-428, 1991

Drug discrimination procedures: differential characteristics of the drug A vs drug B and the drug A vs drug B vs no drug cases. Psychopharmacology 90(3): 341-346, 1986

Prediction of in vivo drug-drug interactions from in vitro data : factors affecting prototypic drug-drug interactions involving CYP2C9, CYP2D6 and CYP3A4. Clinical Pharmacokinetics 45(10): 1035-1050, 2006

Masking of the chlordiazepoxide cue by caffeine in a three-choice CDP-SAL-CAF drug discrimination task. Society for Neuroscience Abstracts 18(1-2): 813, 1992

Multiple precipitations of diazepam withdrawal are reliably detected in the pentylenetetrazole drug discrimination paradigm. Federation Proceedings 45(3): 429, 1986

Therapeutic challenges posed by critical drug-drug interactions in cystic fibrosis. Pediatric Pulmonology 51(S44): S61-S70, 2016

Clinical challenges related to novel oral anticoagulants: drug-drug interactions and monitoring. Haematologica 99(2): E26-E27, 2014

Clinical management of drug-drug interactions in HCV therapy: challenges and solutions. Journal of Hepatology 58(4): 792-800, 2014